170 related articles for article (PubMed ID: 11051385)
1. Hepatorenal syndrome in cirrhotic patients: terlipressine is a safe and efficient treatment; propranolol and digitalic treatments: precipitating and preventing factors?
Duhamel C; Mauillon J; Berkelmans I; Bourienne A; Tranvouez JL
Am J Gastroenterol; 2000 Oct; 95(10):2984-5. PubMed ID: 11051385
[No Abstract] [Full Text] [Related]
2. Terlipressin. Type I hepatorenal syndrome: an extra window of time before liver transplantation.
Prescrire Int; 2006 Dec; 15(86):220. PubMed ID: 17171813
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment of hepatorenal syndrome as a bridge to liver transplantation.
Caraceni P; Santi L; Mirici F; Montanari G; Bevilacqua V; Pinna AD; Bernardi M
Dig Liver Dis; 2011 Mar; 43(3):242-5. PubMed ID: 20833118
[TBL] [Abstract][Full Text] [Related]
4. Terlipressin and albumin combination treatment in hepatorenal syndrome.
Danalioglu A; Cakaloglu Y; Karaca C; Aksoy N; Akyuz F; Ozdil S; Demir K; Besisik F; Boztas G; Mungan Z; Kaymakoglu S; Okten A
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccciii-cccv. PubMed ID: 15244209
[TBL] [Abstract][Full Text] [Related]
5. Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study.
Alessandria C; Ottobrelli A; Debernardi-Venon W; Todros L; Cerenzia MT; Martini S; Balzola F; Morgando A; Rizzetto M; Marzano A
J Hepatol; 2007 Oct; 47(4):499-505. PubMed ID: 17560680
[TBL] [Abstract][Full Text] [Related]
6. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials.
Sagi SV; Mittal S; Kasturi KS; Sood GK
J Gastroenterol Hepatol; 2010 May; 25(5):880-5. PubMed ID: 20074149
[TBL] [Abstract][Full Text] [Related]
7. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
Martín-Llahí M; Pépin MN; Guevara M; Díaz F; Torre A; Monescillo A; Soriano G; Terra C; Fábrega E; Arroyo V; Rodés J; Ginès P;
Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
[TBL] [Abstract][Full Text] [Related]
8. Terlipressin may influence the outcome of hepatorenal syndrome complicating alcoholic hepatitis.
Cervoni JP; Lecomte T; Cellier C; Auroux J; Simon C; Landi B; Gadano A; Barbier JP
Am J Gastroenterol; 1997 Nov; 92(11):2113-4. PubMed ID: 9362205
[TBL] [Abstract][Full Text] [Related]
9. [Vasoconstrictors in the treatment of hepatorenal syndrome].
Ortega R; Calahorra B; Ginès P
Nefrologia; 2002; 22 Suppl 5():56-61. PubMed ID: 12107919
[No Abstract] [Full Text] [Related]
10. Hepatorenal syndrome after treatment of visceral leishmaniasis requiring terlipressin therapy.
Marzano A; Debernardi Venon W; Sacco M; Rizzetto M
Minerva Gastroenterol Dietol; 2015 Sep; 61(3):171-2. PubMed ID: 26161570
[No Abstract] [Full Text] [Related]
11. Terlipressin: an asset for hepatologists!
Sarin SK; Sharma P
Hepatology; 2011 Aug; 54(2):724-8. PubMed ID: 21735463
[No Abstract] [Full Text] [Related]
12. Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: a case-control study.
Alessandria C; Debernardi-Venon W; Carello M; Ceretto S; Rizzetto M; Marzano A
Dig Liver Dis; 2009 Apr; 41(4):298-302. PubMed ID: 19158001
[TBL] [Abstract][Full Text] [Related]
13. Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: a new exception to MELD score in the allocation system to liver transplantation?
Piano S; Morando F; Fasolato S; Cavallin M; Boscato N; Boccagni P; Zanus G; Cillo U; Gatta A; Angeli P
J Hepatol; 2011 Aug; 55(2):491-6. PubMed ID: 21334405
[TBL] [Abstract][Full Text] [Related]
14. Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: PRO.
Belcher JM
Kidney360; 2024 Jun; 5(6):791-794. PubMed ID: 38526157
[No Abstract] [Full Text] [Related]
15. Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.
Kim HR; Lee YS; Yim HJ; Lee HJ; Ryu JY; Lee HJ; Yoon EL; Lee SJ; Hyun JJ; Jung SW; Koo JS; Choung RS; Lee SW; Choi JH
Clin Mol Hepatol; 2013 Dec; 19(4):417-20. PubMed ID: 24459647
[TBL] [Abstract][Full Text] [Related]
16. Terlipressin in hepatorenal syndrome.
Mazur JE; Cooper TB; Dasta JF
Ann Pharmacother; 2011 Mar; 45(3):380-7. PubMed ID: 21386023
[TBL] [Abstract][Full Text] [Related]
17. Terlipressin in 30 patients with hepatorenal syndrome: results of a retrospective study.
von Kalckreuth V; Glowa F; Geibler M; Lohse AW; Denzer UW
Z Gastroenterol; 2009 Jan; 47(1):21-6. PubMed ID: 19156588
[TBL] [Abstract][Full Text] [Related]
18. [A case of peripheral ischemic complication after terlipressin therapy].
Lee JS; Lee HS; Jung SW; Han WS; Kim MJ; Lee SW; Choi JH; Kim CD; Ryu HS; Hyun JH
Korean J Gastroenterol; 2006 Jun; 47(6):454-7. PubMed ID: 16809953
[TBL] [Abstract][Full Text] [Related]
19. Reply: Is right heart assessment vital for evaluating terlipressin-related outcomes in hepatorenal syndrome-acute kidney injury?
Roy A; Kajal K; Izzy M; Sihag BK; Premkumar M
Hepatology; 2024 Jun; 79(6):E163-E164. PubMed ID: 38441911
[No Abstract] [Full Text] [Related]
20. Letter to the Editor: Is right heart assessment vital for evaluating terlipressin-related outcomes in hepatorenal syndrome-acute kidney injury?
Guo Q; Wang J; Wang G; Wang X
Hepatology; 2024 Jun; 79(6):E161-E162. PubMed ID: 38456783
[No Abstract] [Full Text] [Related]
[Next] [New Search]
